Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Drivers
HCA logo

HCA Healthcare Delivers 9.6% Revenue Surge and 29% EPS Growth Amid Policy Headwinds

HCA10-QFiling Date: 10/30/2025
HCA Healthcare, Inc.
Description

What this story covers

HCA Healthcare's Q3 2025 10-Q shows $19.2B revenues up 9.6%, driven by volume growth and pricing, with net income at $1.6B and EPS up 29% to $6.96. Nine-month cash from operations hit $10.3B, funding $7.5B share repurchases and $5B capex. Stable payer mix and expense controls boosted EBITDA margins to 22%. Policy risks like OBBBA Medicaid cuts and expiring tax credits loom, but tech initiatives and geographic diversity enhance resilience. Debt at $44.5B is well-managed with 95% fixed rates.

Story snapshot

CompanyHCA Healthcare, Inc.
TickerHCA
VariantStandard detailed
Duration9:22
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001193125-25-258667

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in